Can intensive treatment alter the progress of established diabetic nephropathy to end-stage renal failure?

被引:22
作者
Feest, TG [1 ]
Dunn, EJ [1 ]
Burton, CJ [1 ]
机构
[1] Southmead Hosp, Richard Bright Renal Unit, Bristol BS10 5NB, Avon, England
关键词
D O I
10.1093/qjmed/92.5.275
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy is now the leading cause of end-stage renal disease in the Western would, and is associated with a higher patient morbidity and mortality than other causes of renal failure, largely because of associated cardiovascular disease. Numerous studies have elucidated the factors which influence its onset and progression. The St Vincent Declaration in 1994 proposed standards for the appropriate management of patients with diabetic nephropathy. We assessed whether referral to a nephrology clinic attempting to apply these standards influenced the progression of diabetic nephropathy. The results show a significant improvement in blood pressure, glycosylated haemoglobin and serum cholesterol following referral. There was a significant reduction in the rate of decline of renal function following referral in 39% of patients. With the possible exception of diabetic control there were no significant differences ire the management of those that did and did not show improvement. The results show that with intensive out-patient clinic monitoring it is possible to improve the quality of patient care, and that even in established diabetic nephropathy it is possible to slow the rate of progression to end-stage venal failure.
引用
收藏
页码:275 / 282
页数:8
相关论文
共 33 条
[1]  
Alaveras AEG, 1997, NEPHROL DIAL TRANSPL, V12, P71
[2]   Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy [J].
Bakris, GL ;
Copley, JB ;
Vicknair, N ;
Sadler, R ;
Leurgans, S .
KIDNEY INTERNATIONAL, 1996, 50 (05) :1641-1650
[3]   TREATMENT OF ARTERIAL-HYPERTENSION IN DIABETIC HUMANS - IMPORTANCE OF THERAPEUTIC SELECTION [J].
BAKRIS, GL ;
BARNHILL, BW ;
SADLER, R .
KIDNEY INTERNATIONAL, 1992, 41 (04) :912-919
[4]  
BERGSTROM J, 1986, CLIN NEPHROL, V25, P1
[5]  
BERGSTROM J, 1989, KIDNEY INT S, V38, pS110
[6]   PROTEINURIA - VALUE AS PREDICTOR OF CARDIOVASCULAR MORTALITY IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
BORCHJOHNSEN, K ;
KREINER, S .
BMJ-BRITISH MEDICAL JOURNAL, 1987, 294 (6588) :1651-1654
[7]  
BORSCHJOHNSEN K, 1985, DIABETOLOGIA, V28, P590
[8]   Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy [J].
Breyer, JA ;
Bain, RP ;
Evans, JK ;
Nahman, NS ;
Lewis, EJ ;
Cooper, M ;
McGill, J ;
Berl, T ;
Rohde, R ;
Hunsicker, LG ;
Lachin, J ;
Greenhouse, SW ;
Verme, DA ;
Turlington, TR ;
Burrows, PK ;
Wish, J ;
Sheehan, J ;
Pohl, M ;
Berl, T ;
Santiago, G ;
Hunsicker, L ;
Kern, EFO ;
Lemann, J ;
Blementhal, S ;
Bresnahan, BS ;
Hebert, L ;
Goldfarb, S ;
Kobrin, S ;
Rodby, R ;
Levey, A ;
McLaughlin, M ;
Williams, M ;
McGill, J ;
Whittler, F ;
Rutecki, G ;
Cattran, D ;
Lietz, S ;
Valaitis, D ;
Hano, J ;
Maxwell, D ;
Porush, J ;
Spitalewitz, S ;
Shapiro, K ;
Adler, S ;
Tolchin, N ;
Hoy, W ;
Bernstein, R ;
Svetkey, L ;
Sharon, Z ;
Rausenbaum, B .
KIDNEY INTERNATIONAL, 1996, 50 (05) :1651-1658
[9]  
*BRIT MED ASS ROYA, 1998, BRIT NAT FORM, V36
[10]  
Burton C. J., 1998, Nephrology Dialysis Transplantation, V13, pA108